1. Home
  2. DHX vs AGEN Comparison

DHX vs AGEN Comparison

Compare DHX & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$3.84

Market Cap

150.3M

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$5.86

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
AGEN
Founded
1991
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.3M
208.2M
IPO Year
2007
1999

Fundamental Metrics

Financial Performance
Metric
DHX
AGEN
Price
$3.84
$5.86
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$6.25
$14.50
AVG Volume (30 Days)
125.3K
8.2M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.00
EPS
0.04
1.02
Revenue
$127,826,000.00
$42,877,086.00
Revenue This Year
N/A
$107.63
Revenue Next Year
$3.52
N/A
P/E Ratio
$94.25
$6.11
Revenue Growth
N/A
89.95
52 Week Low
$1.44
$2.71
52 Week High
$4.33
$8.70

Technical Indicators

Market Signals
Indicator
DHX
AGEN
Relative Strength Index (RSI) 50.15 68.65
Support Level $3.58 $3.16
Resistance Level $4.00 $8.70
Average True Range (ATR) 0.27 0.77
MACD -0.02 0.18
Stochastic Oscillator 20.37 50.00

Price Performance

Historical Comparison
DHX
AGEN

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: